Japanese Phase 1 Multiple Ascending Dose (MAD) Study
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to assess the safety and tolerability of multiple oral
doses of BMS-820836 in healthy Japanese subjects and Japanese patients with depression.